Approaching the asymptote: 20 years later.

[1]  D. Green,et al.  Immunogenic and tolerogenic cell death , 2009, Nature Reviews Immunology.

[2]  W. Paul,et al.  IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation , 2009, Proceedings of the National Academy of Sciences.

[3]  R. Medzhitov,et al.  Immunostimulatory activity of haptenated proteins , 2009, Proceedings of the National Academy of Sciences.

[4]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[5]  Anna M. Keller,et al.  Identification of a dendritic cell receptor that couples sensing of necrosis to immunity , 2009, Nature.

[6]  Akiko Iwasaki,et al.  Inflammasome recognition of influenza virus is essential for adaptive immune responses , 2009, The Journal of experimental medicine.

[7]  Ruslan Medzhitov,et al.  Pattern recognition receptors and control of adaptive immunity , 2009, Immunological reviews.

[8]  D. Hourcade,et al.  Properdin: New roles in pattern recognition and target clearance. , 2008, Molecular immunology.

[9]  S. Yamasaki,et al.  Mincle is an ITAM-coupled activating receptor that senses damaged cells , 2008, Nature Immunology.

[10]  Wei Liu,et al.  TLR-2 and IL-17A in Chitin-Induced Macrophage Activation and Acute Inflammation1 , 2008, The Journal of Immunology.

[11]  Jie-Oh Lee,et al.  Structures of the toll-like receptor family and its ligand complexes. , 2008, Immunity.

[12]  Ruslan Medzhitov,et al.  A mechanism for the initiation of allergen-induced T helper type 2 responses , 2008, Nature Immunology.

[13]  K. Rock,et al.  The inflammatory response to cell death. , 2008, Annual review of pathology.

[14]  A. Macpherson,et al.  The functional interactions of commensal bacteria with intestinal secretory IgA , 2007, Current opinion in gastroenterology.

[15]  Douglas R. McDonald,et al.  Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity , 2007, The Journal of experimental medicine.

[16]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[17]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[18]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[19]  D. Voehringer,et al.  Chitin induces accumulation in tissue of innate immune cells associated with allergy , 2007, Nature.

[20]  Dominique Ferrandon,et al.  Dual Detection of Fungal Infections in Drosophila via Recognition of Glucans and Sensing of Virulence Factors , 2006, Cell.

[21]  B. Beutler,et al.  Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling , 2006, Science.

[22]  Jonathan D. G. Jones,et al.  The plant immune system , 2006, Nature.

[23]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[24]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[25]  E. Pamer,et al.  Innate immune activation and CD4+ T cell priming during respiratory fungal infection. , 2006, Immunity.

[26]  F. Sutterwala,et al.  The Inflammasome: First Line of the Immune Response to Cell Stress , 2006, Cell.

[27]  J. Ruland,et al.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity , 2006, Nature.

[28]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[29]  R. Vance,et al.  Self-tolerance of natural killer cells , 2006, Nature Reviews Immunology.

[30]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[32]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[33]  C. Garlanda,et al.  Pentraxins as a key component of innate immunity. , 2006, Current opinion in immunology.

[34]  I. Michelow,et al.  The mannose-binding lectin: a prototypic pattern recognition molecule , 2005, Current Opinion in Immunology.

[35]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[36]  S. Akira,et al.  Toll-like receptor–independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation , 2005, The Journal of experimental medicine.

[37]  Ruslan Medzhitov,et al.  Control of B-cell responses by Toll-like receptors , 2005, Nature.

[38]  Osamu Takeuchi,et al.  Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.

[39]  S. Lemon,et al.  Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.

[40]  Michael Karin,et al.  Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.

[41]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[42]  R. Medzhitov,et al.  Toll-dependent control mechanisms of CD4 T cell activation. , 2004, Immunity.

[43]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[44]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[45]  S. Thiel,et al.  Collections and ficolins: humoral lectins of the innate immune defense. , 2003, Annual review of immunology.

[46]  Richard J. Laws,et al.  A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease , 2003, The Journal of experimental medicine.

[47]  J. Hoffmann,et al.  The immune response of Drosophila , 2003, Nature.

[48]  D. Kuhns,et al.  Distinct Mutations in IRAK-4 Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections , 2003, The Journal of experimental medicine.

[49]  S. Way,et al.  Cutting Edge: Protective Cell-Mediated Immunity to Listeria monocytogenes in the Absence of Myeloid Differentiation Factor 881 , 2003, The Journal of Immunology.

[50]  S. Foster,et al.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.

[51]  J. Bertin,et al.  Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.

[52]  J. Banchereau,et al.  Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.

[53]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[54]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[55]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[56]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[57]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[58]  Jonathan D. G. Jones,et al.  Plant pathogens and integrated defence responses to infection , 2001, Nature.

[59]  A. Varki,et al.  Siglecs, sialic acids and innate immunity. , 2001, Trends in immunology.

[60]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[61]  D. Nicolae,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[62]  S. Vogel,et al.  Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.

[63]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[64]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[65]  L. del Peso,et al.  Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.

[66]  J. Bertin,et al.  Human CARD4 Protein Is a Novel CED-4/Apaf-1 Cell Death Family Member That Activates NF-κB* , 1999, The Journal of Biological Chemistry.

[67]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[68]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[69]  M. Rothe,et al.  Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide , 1998, The Journal of experimental medicine.

[70]  A. Gurney,et al.  Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling , 1998, Nature.

[71]  B. Trask,et al.  Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. , 1998, Blood.

[72]  P. Stahl,et al.  The mannose receptor is a pattern recognition receptor involved in host defense. , 1998, Current opinion in immunology.

[73]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[75]  D. Fearon.  Seeking wisdom in innate immunity , 1997, Nature.

[76]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[77]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[78]  M. Gayle,et al.  T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*) , 1996, The Journal of Biological Chemistry.

[79]  D. Fearon,et al.  A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. , 1995, Science.

[80]  I. Thesleff,et al.  Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages , 1995, Cell.

[81]  S. Dinesh-Kumar,et al.  The product of the tobacco mosaic virus resistance gene N: Similarity to toll and the interleukin-1 receptor , 1994, Cell.

[82]  K. Anderson,et al.  A processed form of the Spätzle protein defines dorsal-ventral polarity in the Drosophila embryo. , 1994, Development.

[83]  R. Steinman,et al.  Zanvil Alexander Cohn 1926-1993 , 1994, The Journal of experimental medicine.

[84]  W. Yokoyama,et al.  MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells , 1992, Nature.

[85]  N. Gay,et al.  Drosophila Toll and IL-1 receptor , 1991, Nature.

[86]  R. Ezekowitz.  Ante-antibody immunity , 1991, Current Biology.

[87]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[88]  S. Meri,et al.  Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[89]  E. Unanue,et al.  T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[90]  K. Anderson,et al.  The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein , 1988, Cell.

[91]  R. Schwartz,et al.  Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.

[92]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[93]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[94]  T. Taniguchi,et al.  The nucleotide sequence of human fibroblast interferon cDNA. , 1980, Gene.

[95]  K. Cantell,et al.  Synthesis in E. coli of a polypeptide with human leukocyte interferon activity , 1980, Nature.

[96]  R. Macdermott,et al.  Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. , 1980, Journal of immunology.

[97]  A. Coutinho,et al.  Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide , 1977, European journal of immunology.

[98]  D. Morrison,et al.  Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS , 1976, The Journal of experimental medicine.

[99]  K. Lafferty,et al.  A new analysis of allogeneic interactions. , 1975, The Australian journal of experimental biology and medical science.

[100]  A. Coutinho,et al.  Immune Activation of B Cells: Evidence for‘One Nonspecific Triggering Signal' Not Delivered by the Ig Receptors , 1974, Bollettino dell'Istituto sieroterapico milanese.

[101]  R. Steinman,et al.  IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE , 1973, The Journal of experimental medicine.

[102]  O. Götze,et al.  THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION , 1971, The Journal of experimental medicine.

[103]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.

[104]  D. W. Weiss,et al.  High Susceptibility of Strain A Mice to Endotoxin and Endotoxin-Red Blood Cell Mixtures , 1965, Journal of bacteriology.

[105]  J. Lederberg.  Genes and antibodies. , 1959, Science.

[106]  R. Valentine,et al.  Virus interference. II. Some properties of interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[107]  J. Lindenmann,et al.  Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[108]  R. Good,et al.  Effect of Meningococcal Endotoxin on the Immune Response.∗ , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[109]  A. Wardlaw,et al.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. , 1954, Science.

[110]  P. Medawar,et al.  ‘Actively Acquired Tolerance’ of Foreign Cells , 1953, Nature.

[111]  K. Landsteiner,et al.  The Specificity of Serological Reactions , 1936, The Indian Medical Gazette.

[112]  S. Akira,et al.  Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans , 2007, Nature Immunology.

[113]  S. Gordon,et al.  Dectin-1 is required for β-glucan recognition and control of fungal infection , 2007, Nature Immunology.

[114]  S. Gordon,et al.  Dectin-1 is required for beta-glucan recognition and control of fungal infection. , 2007, Nature immunology.

[115]  C. Coban,et al.  A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA , 2006, Nature Immunology.

[116]  R. Medzhitov,et al.  Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. , 2006, Immunity.

[117]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[118]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[119]  Adrian Ozinsky,et al.  Phagocytosis of microbes: complexity in action. , 2002, Annual review of immunology.

[120]  G. D. Brown,et al.  Immune recognition. A new receptor for beta-glucans. , 2001, Nature.

[121]  S. Chen,et al.  Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. , 1999, The Journal of biological chemistry.

[122]  C. Gerard.  For whom the bell tolls , 1998 .

[123]  E. Kopp,et al.  NF-kappa B and rel proteins in innate immunity. , 1995, Advances in immunology.

[124]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[125]  N. Nomura,et al.  Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement). , 1994, DNA research : an international journal for rapid publication of reports on genes and genomes.

[126]  N. Nomura,et al.  Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. , 1994, DNA research : an international journal for rapid publication of reports on genes and genomes.

[127]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[128]  F. Burnet.  The clonal selection theory of acquired immunity , 1959 .